When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Does Medicare cover Xarelto? - AOL

   www.aol.com/lifestyle/does-medicare-cover...

   Xarelto is a brand name for the drug rivaroxaban. Parts of Medicare cover the cost of prescription medication, including Part A, Part D, and Advantage plans.

3. These are the drugs that are getting cheaper under new ... - AOL

   www.aol.com/news/drugs-getting-cheaper-under...

   Drugs used to treat heart disease, cancer, diabetes, blood clots and more are going to get cheaper, potentially saving money for million of people on Medicare. Here's what's changing.

4. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   Antistasin, the first discovered naturally occurring direct Xa inhibitor Rivaroxaban, the first synthetic direct Xa inhibitor marketed as a drug Prior to the introduction of direct factor Xa inhibitors, vitamin K antagonists such as warfarin were the only oral anticoagulants for over 60 years, and together with heparin have been the main blood ...

5. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [8] It is taken by mouth. [8]

6. Discovery and development of direct Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Discovery_and_development...

   Four drugs from the class of direct Xa inhibitors are marketed worldwide. Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [1] The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States in 2012. [3]

7. Bayer's patent for blood thinner Xarelto invalid, UK ... - AOL

   www.aol.com/news/bayers-patent-blood-thinner...

   Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto drug generated ...